GT Biopharma (GTBP) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free GTBP Stock Alerts $3.75 +0.10 (+2.74%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineRecap: GT Biopharma Q4 Earningsbenzinga.com - March 27 at 10:26 AMGT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial Resultsglobenewswire.com - March 26 at 5:00 PMGT Biopharma (GTBP) Price Target Increased by 2900.00% to 153.00msn.com - February 25 at 8:43 AMGTBP Feb 2024 2.500 callfinance.yahoo.com - February 14 at 8:18 AMmarketbeat.com - February 5 at 6:06 AMGT Biopharma, Inc. (GTBP)finance.yahoo.com - February 2 at 1:15 PMGT Biopharma Announces Reverse Stock Split Updatemsn.com - February 2 at 1:15 PMGT Biopharma Stock (NASDAQ:GTBP), Short Interest Reportbenzinga.com - February 2 at 8:15 AMGT Biopharma, Inc. Announces 1-for-30 Reverse Stock Splitfinance.yahoo.com - February 1 at 12:07 PMBuy Rating for GT Biopharma: High Efficacy and Expanded Potential in Oncology Therapeuticsmarkets.businessinsider.com - December 14 at 12:31 PMLeading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of Stockholdersfinance.yahoo.com - December 6 at 1:31 PMGT Biopharma submits IND to FDA for CD33+ leukemia therapymsn.com - December 4 at 1:30 PMGT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemiafinance.yahoo.com - December 4 at 1:30 PMGT Biopharma: Strong Q3 Performance and Promising Pipeline Progression Justify Buy Ratingmarkets.businessinsider.com - November 23 at 1:38 AMGT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meetingfinance.yahoo.com - November 6 at 4:04 PMGT Biopharma GAAP EPS of -$0.06msn.com - November 1 at 10:33 AMGT Biopharma Reports Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 1 at 10:33 AMGT Biopharma, Inc. (GTBP) May Find a Bottom Soon, Here's Why You Should Buy the Stock Nowfinance.yahoo.com - August 24 at 4:23 PMH.C. Wainwright Remains a Buy on GT Biopharma (GTBP)markets.businessinsider.com - August 8 at 7:51 AMGT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2023 Financial Resultsfinanznachrichten.de - August 7 at 8:01 PMGT Biopharma Reports Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 7 at 8:01 PMGT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023finance.yahoo.com - August 3 at 3:09 PMHere's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock Nowmsn.com - June 2 at 3:55 PMAll You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to Buymsn.com - May 19 at 2:28 PMHC Wainwright & Co. Reiterates GT Biopharma (GTBP) Buy Recommendationmsn.com - May 18 at 10:21 AMEF Hutton Reiterates GT Biopharma (GTBP) Hold Recommendationmsn.com - May 17 at 8:38 AMGT Biopharma, Inc.: GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 16 at 9:12 AMAnalysts Offer Insights on Healthcare Companies: Cara Therapeutics (CARA), GT Biopharma (GTBP) and Spruce Biosciences (SPRB)markets.businessinsider.com - May 16 at 9:12 AMGT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 15 at 8:19 PMGT Biopharma (GTBP) Gets a Buy from H.C. Wainwrightmarkets.businessinsider.com - April 3 at 7:53 AMGT Biopharma Inc Up 20.52% To $0.56 After Earnings Missbenzinga.com - April 2 at 5:39 PMGT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updatefinanznachrichten.de - April 1 at 4:27 PMGT Biopharma Stock (NASDAQ:GTBP), Dividendsbenzinga.com - April 1 at 6:25 AMEF Hutton Keeps Their Hold Rating on GT Biopharma (GTBP)markets.businessinsider.com - March 31 at 3:22 PMGT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 30 at 9:27 PMGT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual Conferencefinance.yahoo.com - February 24 at 6:05 PMGT Biopharma Issues Open Letter to Shareholders Detailing Recent Activitiesfinance.yahoo.com - February 2 at 10:11 AMGT Biopharma slips on $6.5M stock offeringmsn.com - December 30 at 3:18 PMGT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officerfinance.yahoo.com - December 14 at 12:21 PMFate Therapeutics hits 52-week low after preclinical data on leukemia treatmentmsn.com - December 12 at 5:36 PMGT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022finance.yahoo.com - December 12 at 5:36 PMGT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer's (SITC) 37th Annual Meetingbenzinga.com - November 10 at 4:48 PMGT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meetingfinance.yahoo.com - November 10 at 4:48 PMGT Biopharma to Present New Data on Novel Dual-Antigen Targeting Approach Against AML at Upcoming 2022 ASH Annual Meetingfinance.yahoo.com - November 3 at 1:32 PMGT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Updatefinance.yahoo.com - November 1 at 11:35 AMHere's Why We're Watching GT Biopharma's (NASDAQ:GTBP) Cash Burn Situationfinance.yahoo.com - October 26 at 2:28 PMGT Biopharma Presents at LD Micro on October 26, 2022 at 4:30 pm PSTfinance.yahoo.com - October 25 at 6:19 PMGT Biopharma Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meetingfinance.yahoo.com - October 6 at 1:16 PMGT Biopharma Announces Adjournment of Special Shareholders Meetingfinance.yahoo.com - October 4 at 7:38 PMGTBP GT Biopharma, Inc.seekingalpha.com - September 15 at 8:29 AM Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). GTBP Media Mentions By Week GTBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTBP News Sentiment▼1.000.40▲Average Medical News Sentiment GTBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTBP Articles This Week▼10▲GTBP Articles Average Week Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Oragenics News Synaptogenix News Alzamend Neuro News Bright Minds Biosciences News PaxMedica News China Pharma News Processa Pharmaceuticals News ZyVersa Therapeutics News Kintara Therapeutics News NexImmune News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GTBP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
